PPCB vs SCHW · P/E 0.0, $3.9M cap vs P/E 19, rev $23.92B
Propanc Biopharma, Inc. Common Stock (PPCB) versus Charles Schwab Corp (SCHW) — a side-by-side from cached financials, not a winner call.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Walt Bettinger.
PPCB does not have a complete income-statement cache yet.
Latest reported SCHW revenue for 2025-12-31 was $23.92B. Net income was $8.85B. Revenue was up 22.0% from 2024-12-31 to 2025-12-31. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
PPCB currently screens at market cap $3.9M and trailing P/E 0.0. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Not investment advice. Open the PPCB and SCHW stock pages for the full models.
Not investment advice.